News Releases Keyword Search Year None20232022202120202019201820172016 Nov-09-2021 Oncternal Therapeutics to Present at the 12th Annual Jefferies London Healthcare Conference Nov-04-2021 Oncternal Provides Business Update and Announces Third Quarter 2021 Financial Results Nov-03-2021 Oncternal Therapeutics Joins Karolinska Institutet’s NextGenNK Competence Center for the Development of Next Generation NK Cell-Based Cancer Immunotherapies Nov-02-2021 Oncternal Therapeutics Announces Formation of Cell Therapy Scientific Advisory Board Nov-01-2021 Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4) Oct-29-2021 Oncternal Therapeutics to Provide Business Update and Report Third Quarter 2021 Financial Results Oct-05-2021 Oncternal Therapeutics Announced Pre-Clinical Data from ONCT-534, an Androgen Receptor N-Terminal-Domain-Binding Small Molecule Degrader, Was Accepted for Virtual Poster Presentation at AACR-NCI-EORTC Virtual International Conference on Molecular Targets Oct-01-2021 Oncternal Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Sep-20-2021 Oncternal Therapeutics and Celularity Enter into Research Collaboration to Evaluate Targeted Placental-Derived Cellular Therapies Sep-09-2021 Oncternal Therapeutics to Participate in September Investor Conferences Pagination First page « first Previous page ‹ previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page next › Last page last »